Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
VentriPoint Diagnostics ( (TSE:VPT) ) has shared an announcement.
Ventripoint Diagnostics has issued 1,164,044 common shares, with regulatory approval, to satisfy C$104,752 in interest owed on several tranches of 10% convertible debentures issued between 2024 and early 2025, valuing the shares at a deemed price of C$0.09 each and subjecting them to a standard four-month-plus-one-day hold period. The move allows the company to preserve cash by paying debenture interest in equity rather than cash, while the share issuance is structured so as not to create a new control position among shareholders, limiting immediate governance impact but modestly diluting existing investors.
The most recent analyst rating on (TSE:VPT) stock is a Hold with a C$0.12 price target. To see the full list of analyst forecasts on VentriPoint Diagnostics stock, see the TSE:VPT Stock Forecast page.
Spark’s Take on TSE:VPT Stock
According to Spark, TipRanks’ AI Analyst, TSE:VPT is a Neutral.
The score is held back primarily by weak financial fundamentals (ongoing losses, cash burn, and negative equity). Technicals are moderately constructive with improving momentum, and corporate updates are directionally positive, but valuation support is limited due to negative earnings and no dividend indicated.
To see Spark’s full report on TSE:VPT stock, click here.
More about VentriPoint Diagnostics
Ventripoint Diagnostics Ltd. is a medical technology company specializing in AI-enhanced cardiac imaging, applying artificial intelligence to echocardiography. Its flagship VMS+ system uses proprietary knowledge-based reconstruction technology to deliver cardiac volumetric measurements comparable to MRI, offering a more affordable, gold-standard alternative that works with ultrasound systems from any vendor. The company’s solutions are cleared for use in the United States, Europe and Canada, targeting cardiologists seeking more accurate and accessible tools for cardiac patient management.
Average Trading Volume: 139,373
Technical Sentiment Signal: Sell
Current Market Cap: C$20.96M
See more data about VPT stock on TipRanks’ Stock Analysis page.